Patent Assignment
Reel/Frame 056890/0304
Corrective Assignment to Correct the the Spelling of the First Inventor Last Name and the Receiving Party Address. Previously Recorded at Reel: 039122 Frame: 0970. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2021-07-15
Pages: 9
Assignors
CLARKE, ADAM
Executed: 2013-05-03
POLLARD, MATTHEW
Executed: 2013-05-03
DOYLE, ANTHONY GERARD
Executed: 2013-05-03
BEHRENS, COLLETTE
Executed: 2013-06-28
YAMAGISHI, TETSUO
Executed: 2013-05-03
WILSON, DAVID S., JR.
Executed: 2013-05-13
POGUE, SARAH L.
Executed: 2013-06-10
TAURA, TETSUYA
Executed: 2013-05-07
Assignee
CEPHALON AUSTRALIA PTY. LTD. (NOW TEVA PHARMACEUTICALS AUSTRALIA PTY. LTD.)
LEVEL 2, 37 EPPING ROAD, MACQUARIE PARK, 2113, AUSTRALIA
Covered Property
(1)
Anti-CD38 Antibodies and Fusions to Attenuated Interferon Alpha-2B
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2016
From: CLARK, ADAM; POLLARD, MATTHEW; DOYLE, ANTHONY GERARD; BEHRENS, COLLETTE
To: TEVA PHARMACEUTICALS AUSTRALIA PTY. LTD.
Reel/Frame 039122/0970 →
Change of Name
Oct 3, 2018
From: CEPHALON AUSTRALIA PTY. LTD.
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 047050/0007 →
Corrective Assignment to Correct the Assignee City of Residence Previously Recorded at Reel: 47050 Frame: 007. Assignor(S) Hereby Confirms the Assignment.
Aug 11, 2021
From: CEPHALON AUSTRALIA PTY. LTD.
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 057229/0388 →